Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-390,370
Closed -$44M 47
2021
Q2
$44M Sell
390,370
-1,225
-0.3% -$138K 1.24% 21
2021
Q1
$42.4M Sell
391,595
-640
-0.2% -$68.5K 1.23% 21
2020
Q4
$42M Buy
392,235
+89,915
+30% +$8.64M 1.31% 20
2020
Q3
$26.5M Buy
302,320
+96,320
+47% +$9.07M 1.03% 23
2020
Q2
$20.2M Buy
+206,000
New +$18.1M 0.81% 25

Other funds holding ABBV

Tweedy, Browne Co's ABBV Position: Q3 2021 in Review

Tweedy, Browne Co sold out of AbbVie (ABBV) in Q3 2021, closing a stake of 390,370 shares — an estimated $44M sold.

Tweedy, Browne Co first reported a position in ABBV in Q2 2020 and held it in 5 quarters. The position peaked at $44M in Q2 2021. 2,654 funds tracked by Wall St. Rank hold ABBV as of Q3 2021.

  • Tweedy, Browne Co reported no remaining AbbVie position as of Q3 2021 after selling out during the quarter.
  • Tweedy, Browne Co sold 390,370 AbbVie shares in Q3 2021, an estimated $44M.
  • Tweedy, Browne Co first reported a position in AbbVie in Q2 2020 and held it in 5 quarters.
  • Tweedy, Browne Co's AbbVie position peaked at $44M in Q2 2021.
  • 2,654 funds tracked by Wall St. Rank held AbbVie as of Q3 2021.

Based on Tweedy, Browne Co's 13F filing for Q3 2021, filed 12 Nov 2021.